CXCL1 and bacterial infectious disease: As expected, bacterial infection induced a systemic inflammatory response characterized by increased plasmatic levels of TNFα, IL-6, IL-12, IFNγ and KC/GRO (CXCL-1) compared to PBS-treated mice (Fig 4A).